Video News June 28, 2021Intellia, Regeneron complete first systemic delivery of CRISPR in body 0 0 Share
Video News June 28, 2021Intellia, Regeneron conplete first systemic delivery of CRISPR in body 0 0 Share
Press Release June 28, 2021Dupixent® (dupilumab) SmPC updated with long-term data reinforcing well-established safety profile in adults with moderate-to-severe atopic dermatitis 0 0 Share
Press Release June 25, 2021Libtayo® (cemiplimab) Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma 0 0 Share
Press Release June 25, 2021Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma 0 0 Share
Press Release June 25, 2021Libtayo® (cemiplimab) Approved by the European Commission for First-Line Treatment of Patients with Advanced Non-small Cell Lung Cancer with ≥50% PD-L1 Expression 0 0 Share
Press Release June 25, 2021Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression 0 0 Share
Company Ticker News June 23, 20213 Companies With Low Debt to Buy in Case Interest Rates Rise 0 0 Share
Company Ticker News June 22, 2021Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at BMO Biopharma Day Conference (Transcript) 0 0 Share
